medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2012, Number 3

<< Back Next >>

Rev Biomed 2012; 23 (3)

Social determinants related with treatment of Tuberculosis in Yucatan

Heredia-Navarrete MR, Puc-Franco M, Caamal-Ley Á, Vargas-González A

Language: Spanish
References: 29
Page: 113-120
PDF size: 211.73 Kb.


ABSTRACT

Introduction. TB is associated with poverty, malnutrition and poor sanitary conditions. When coupled with HIV co-infections and the emergence of drug-resistant TB strains, these factors are considered to be the primary causes of continuing TB infection rates. Knowledge of TB, socioeconomic levels, and levels of medical care are important elements for patient adherence to the treatments. This research explores the importance of patient’s social determinants during the treatment of the disease.
Materials and Methods. This study included quantitative, qualitative, non-experimental, transectional, descriptive and correlational evaluations on a group of 31 patients in the State of Yucatan. Likert format survey protocols were applied, to measure determining social factors and the rates of patient adherence to treatment protocols.
Results. 83.8% of the interviewees belong to a low socio-economic level. 61.3% live in extreme poverty. 83.4% attended in health centers close to their home and mentioned that the medical personnel instructions were confusing and that they found the diagnostic procedures uncomfortable and annoying. 54.8% knew little or nothing of the disease and feared family or community rejection. Medication caused discomfort in 80.6% of the patients and 16.1% left treatment, dropping out of the study.
Discussion. Yucatán’s problems for TB treatment are related with social determinants like education, socioeconomical level and the patient perceptions. For these reasons we determined that patients must be properly educated and informed about TB. Improved patient-doctor relationship and adequate training of the medical personnel can signifi cantly contribute to better control of tuberculosis in Yucatan, since these are key factors in keeping patients in treatment programs and better controlling the disease.


REFERENCES

  1. García-Espinosa G. Aves silvestres en el surgimiento de enfermedades infecciosas: Escenario en México. Los avicultores y su entorno, 2007; 10:53-6.

  2. Humphreys, M. The tuberculosis: the consumption and civilization. En: Kiple, K. F. Plague, pox and pestilence. Disease in History. 1977. Londres: Weidenfeld & Nicolson, p. 136

  3. García-García, ML, ME Mayar-Maya, L. Ferreyra- Reyes, L. M. Palacios Martínez, C. Alvarez- García, JL Valdespino Gómez. Efi cacia y efi ciencia del tratamiento antituberculoso en jurisdicciones sanitarias de Morelos. Sal Pub Mex 1988; 40:421-9.

  4. Ponce-de-Leon A, Garcia-Garcia MdL, Garcia- Sancho MC, Gomez-Perez FJ, Valdespino-Gomez JL, Olaiz-Fernandez G, et al. Tuberculosis and diabetes in Southern Mexico. Diab Care 2004; 27:1584-90

  5. Situación actual de la Tuberculosis en México, Avances y Desafíos; XV Curso de Actualización en el Diagnóstico y Tratamiento de la Tuberculosis en Niños y Adultos. Programa del En marcha contra la Tuberculosis Orientemos la lucha contra la eliminación. México 2010. Disponible en: http:// www.cenave.gob.mx/tuberculosis/XV%20curso%20 hgm%202011/lunes%202011/Situaci%C3%B3n%20 y%20retos%20TB%20Curso%202011%20HGM.pdf

  6. Zavala-Espinoza JJ, de Jesús-Alejandro JA, Patrónde Treviño A, Cantú-Martínez PC. Percepciones relacionadas con la tuberculosis pulmonar, en los municipios del sur del Estado de Nuevo León, México. Rev Sal Pub Nut 2004; 5. Ver en (htttp://www.respyn. uanl.mx/v/1/articulos/tuber-nl.htm)

  7. Álvarez-Gordillo GC, Dorantes-Jiménez JE, Molina-Rosales, D. La búsqueda de atención para la tuberculosis en Chiapas, México. Rev Panam Sal Pub, 2001; 9:285-93.

  8. Rojas-Soriano R. Crisis, salud-enfermedad y práctica médica. 1ª ed. México, D.F.: Ed. Plaza y Valdés; 1990; pp 22-27.

  9. Berlinguer G. Causas sociales e implicancias morales de las enfermedades. 2008. Disponible en: http://www.fiocruz.br/ccs/cgi/cgilua.exe/sys/start. htm?infoid=798&sid=4

  10. Hernández SR, Fernández CC, Baptista LP. Metodología de la investigación. Cuarta Edición. México, D.F.: Ed. Mc Graw-Hill; 2006. pp 208.

  11. Sánchez, F. y otros. Psicología social. Primera Edición. Madrid: Ed. McGraw-Hill; 1998.

  12. Méndez-Castellano H, de Méndez MC. Sociedad y estratifi cación: método Graffar-Méndez Castellano. Caracas, Venezuela: Ed. Fundacredesa; 1994. pp 206

  13. Cáceres FM. 2004. Factores de riesgo para abandono (no adherencia) del tratamiento antituberculosos. MedUNAB; 2004; 7:172-80

  14. Liefooghe R, Suetens C. Meulemans H, Moran MD, Muynck A. A randomized trial of de impact of counselling on treatment adherence of tuberculosis patients in Sialkot, Pakistan. Int J Tub Lung Dis 1999; 3:1073-80.

  15. Galván F, Santiuste C. Factores relacionados con el cumplimiento de la quimioprofilaxis contra la tuberculosis. Med Clín (Barc);1998; 11:655-7.

  16. Van der Werf TS, Dade GK, Van der Mark TW. Patient compliance with tuberculosis treatment in Ghana: factors infl uencing adherence to therapy in a rural service programme. Tubercle 1990; 71:247-52.

  17. Sumartojo E. When tuberculosis treatment fails. A social behavior account of patient adherence. Am Rev Respir Dis; 1993; 147:1311-20.

  18. Marín Reyes F. Rodríguez Moran M. Apoyo familiar en el apego al tratamiento de la hipertensión arterial esencial. Salud Púb Méx 2001; 43:336-9.

  19. Liefooghe R, Muyinck AD. The dynamics of tuberculosis treatment adherence. J Pak Med Assoc 2001; 51:3-9.

  20. Wardman AG, Knox AJ, Muers MF, Page RL. Profiles of nom-compliance with antituberculosis therapy. Br J Dis Chest 1988; 82:285-9.

  21. Pozsick CJ. Compliance with tuberculosis therapy. Med Clin North Am 1993; 77:1289-301.

  22. Ferrer X, Kirschbaum A, Toro J, Jadue J, Muñoz M, Espinoza A. Adherencia al tratamiento de la tuberculosis del adulto en Santiago, Chile. Bol Ofi cina Sanit Panam 1991; 111:423-31.

  23. Mangtani P, Jolley DJ, Watson JM, Rodrigues LC. Socioeconomic deprivation and notifi cation rates for tuberculosis in London during 1892-1991. Br Med J 1995; 310:963-6.

  24. Chaulet P. Compl iance wi th ant i tuberculous chemotherapy in in developing countries. Tubercle 1987; 68:19-24.

  25. Homedes N, Ugalde A. Estudios sobre el cumplimiento del paciente en países en desarrollo. Bol Of Sanit Panam 1994;116:518-34.

  26. Gavira R, Gómez F, Otero MJ, Barrueco M, Dominguez-Gil A. Seguimiento al tratamiento antituberculoso. Rev Clin Esp 1994; 42:677-81.

  27. Gelband H. Regimens of less than six months for treating tuberculosis. Cochrane Database Syst Rev. 2000; 2:CD001362.

  28. Orozco LC, Hernández R, de Usta CY, Cerra M, Camargo D. Factores de riesgo para el abandono (no adherencia) del tratamiento antituberculoso. Médicas UIS 1998; 12:169-72.

  29. Sumartojo EM, Geiter LJ, Miller B, Hale BE. Can physicians treat tuberculosis? Report on a national survey of physicians practices. Am J Pub Health 1997; 87:2008-11.




2020     |     www.medigraphic.com